Morphine Suspended Phase 2 Trials for Malignancies / Cancer Related Pain (Breakthrough Pain) Treatment

IndicationsStatusPurposePhase
SuspendedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03564548Inhaled Synthetic Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain